Clinical Implementation of Personalized Medicine. Speakers and panelists will illustrate how physicians are incorporating genetic data into the treatment of various diseases and will discuss what the challenges are in bringing more genetically-guided therapy into the clinic.
Biomarkers & Genomics. Speakers and panelists will provide case studies exploring how diagnostics companies/developers of biomarkers and labs are working with drug developers to bring to market new companion diagnostics and targeted therapies to ensure greater efficacy and thus better patient outcomes.
Genomic Data: Infrastructure, Interpretation & Outcomes. Next generation, exome, and whole genome sequencing are accelerating the creation of even more data whose use is critical to the growth of personalized medicine. Speakers and panelists will explore clinical, ethical, technological and business strategy issues related to data collection, sharing and use in the context of the growth needs for personalized medicine.
New Stakeholders & Changing Relationships. Speakers and panelists will discuss the challenges that still exist in terms of reimbursement of molecular diagnostics and lab-developed tests which help guide personalized healthcare. Insurers and reimbursement experts will present their viewpoints and analysis of emerging policies regarding personalized medicine.